These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 2524677
21. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats. Arnt J. Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950 [Abstract] [Full Text] [Related]
22. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice. Gleason SD, Shannon HE. Eur J Pharmacol; 1998 Jan 12; 341(2-3):135-8. PubMed ID: 9543230 [Abstract] [Full Text] [Related]
23. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B. Eur J Pharmacol; 1997 May 01; 325(2-3):145-53. PubMed ID: 9163561 [Abstract] [Full Text] [Related]
24. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Gudelsky GA, Koenig JI, Meltzer HY. Neuropharmacology; 1986 Dec 01; 25(12):1307-13. PubMed ID: 2951611 [Abstract] [Full Text] [Related]
25. Discriminative stimulus properties of the serotonergic compound eltoprazine. Ybema CE, Slangen JL, Olivier B, Mos J. J Pharmacol Exp Ther; 1992 Mar 01; 260(3):1045-51. PubMed ID: 1532031 [Abstract] [Full Text] [Related]
26. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. Schoeffter P, Hoyer D. J Pharmacol Exp Ther; 1990 Jan 01; 252(1):387-95. PubMed ID: 2137176 [Abstract] [Full Text] [Related]
27. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo. Gartside SE, Cowen PJ, Hjorth S. Eur J Pharmacol; 1990 Dec 04; 191(3):391-400. PubMed ID: 1964908 [Abstract] [Full Text] [Related]
28. The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock. Heal DJ, Smith SL. Neuropharmacology; 1988 Dec 04; 27(12):1239-48. PubMed ID: 2977427 [Abstract] [Full Text] [Related]
29. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands. Olivier B, Molewijk HE, van der Heyden JA, van Oorschot R, Ronken E, Mos J, Miczek KA. Neurosci Biobehav Rev; 1998 Dec 04; 23(2):215-27. PubMed ID: 9884114 [Abstract] [Full Text] [Related]
30. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons. Jackson DA, White SR. Neuropharmacology; 1990 Sep 04; 29(9):787-97. PubMed ID: 2149874 [Abstract] [Full Text] [Related]
31. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats. Jackson HC, Kitchen I. Neuropharmacology; 1989 Jun 04; 28(6):635-42. PubMed ID: 2526930 [Abstract] [Full Text] [Related]
32. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. Van de Kar LD, Carnes M, Maslowski RJ, Bonadonna AM, Rittenhouse PA, Kunimoto K, Piechowski RA, Bethea CL. J Pharmacol Exp Ther; 1989 Nov 04; 251(2):428-34. PubMed ID: 2553918 [Abstract] [Full Text] [Related]
33. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Goodwin GM, De Souza RJ, Green AR. Psychopharmacology (Berl); 1986 Nov 04; 89(3):382-7. PubMed ID: 2941817 [Abstract] [Full Text] [Related]
34. Serotonergic 5-HT2A/2C receptors are involved in prolactin secretion in hyperestrogenic rats. Mallmann ES, Paixão L, Ribeiro MF, Spritzer PM. Neurosci Lett; 2014 Oct 17; 582():71-4. PubMed ID: 25220702 [Abstract] [Full Text] [Related]
35. Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists. Gudelsky GA, Koenig JI, Meltzer HY. Neuropharmacology; 1987 Jul 17; 26(7A):707-12. PubMed ID: 2957607 [Abstract] [Full Text] [Related]
36. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. Peroutka SJ. J Neurochem; 1986 Aug 17; 47(2):529-40. PubMed ID: 2942638 [Abstract] [Full Text] [Related]
37. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Berendsen HH, Broekkamp CL. Br J Pharmacol; 1990 Nov 17; 101(3):667-73. PubMed ID: 2150180 [Abstract] [Full Text] [Related]
38. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Vicentic A, Li Q, Battaglia G, Van de Kar LD. Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368 [Abstract] [Full Text] [Related]
39. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS, Assié MB, Koek W. J Pharmacol Exp Ther; 1997 Aug 10; 282(2):747-59. PubMed ID: 9262338 [Abstract] [Full Text] [Related]
40. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster. Richter A, Löscher W. Pharmacol Biochem Behav; 1995 Dec 10; 52(4):655-65. PubMed ID: 8587901 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]